Trametinib Inhibits the Growth and Aerobic Glycolysis of Glioma Cells by Targeting the PKM2/c-Myc Axis
Gliomas are primary tumors originating from glial progenitor cells. Traditional treatments, including surgery, radiotherapy, and chemotherapy, have many limitations concerning the prognosis of patients with gliomas. Therefore, it is important to find novel drugs to effectively treat gliomas. Trameti...
Saved in:
Main Authors: | Mingjun Gao (Author), Jin Yang (Author), Hailong Gong (Author), Yuancai Lin (Author), Jing Liu (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2021-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Dihydroartemisinin Inhibits the Proliferation of Leukemia Cells K562 by Suppressing PKM2 and GLUT1 Mediated Aerobic Glycolysis
by: Gao P, et al.
Published: (2020) -
The combination of dabrafenib/trametinib is approved for the treatment of pediatric glioma
by: article Editorial
Published: (2023) -
Chemistry Behind the Immunomodulatory Activity of Astragalus membranaceus
by: Mallique Qader, et al.
Published: (2021) -
Aqueous Extract of Rhubarb Promotes Hepatotoxicity via Facilitating PKM2-Mediated Aerobic Glycolysis in a Rat Model of Diethylnitrosamine-Induced Liver Cancer
by: Zhao A, et al.
Published: (2024) -
Circulating tumor DNA: a noninvasive biomarker for tracking ovarian cancer
by: Fang Yang, et al.
Published: (2021)